|
| Click above to purchase the entire issue for only $30.00! |
| Article Cost: $10.00 |
 |
|
| Briefings on The Joint Commission |
| July 2008 |
| Heparin recall brings attention to policies |
| Editor's note: This feature explores problematic Joint Commission standards with expert advice from BOJ advisors. This month, Elizabeth Di Giacomo-Geffers, RN, MPH, CNAA, BC, a healthcare consultant in Trabuco Canyon, CA, discusses the recent recall of contaminated heparin doses and its effect on medication management standards.
Anticoagulation drugs have been in the spotlight already in the past year, primarily due to National Patient Safety Goal #3E, which targets the safe use of these drugs. |
| Briefings on The Joint Commission subscribers, please sign on for access |
|